Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single-cell resolution

被引:22
作者
Chambliss, Allison B. [1 ,2 ,3 ]
Wu, Pei-Hsun [1 ,2 ,3 ]
Chen, Wei-Chiang [1 ,2 ,3 ]
Sun, Sean X. [2 ,3 ,4 ]
Wirtz, Denis [1 ,2 ,3 ]
机构
[1] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Phys Scioncol Ctr, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
epigenetics; high-throughput; microscopy; HISTONE ACETYLATION; CANCER; EPIGENETICS; INHIBITORS; TUMOR;
D O I
10.1096/fj.12-227108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Heterogeneity of cellular phenotypes in asynchronous cell populations placed in the same biochemical and biophysical environment may depend on cell cycle and chromatin modifications; however, no current method can measure these properties at single-cell resolution simultaneously and in situ. Here, we develop, test, and validate a new microscopy assay that rapidly quantifies global acetylation on histone H3 and measures a wide range of cell and nuclear properties, including cell and nuclear morphology descriptors, cell-cycle phase, and F-actin content of thousands of cells simultaneously, without cell detachment from their substrate, at single-cell resolution. These measurements show that isogenic, isotypic cells of identical DNA content and the same cell-cycle phase can still display large variations in H3 acetylation and that these variations predict specific phenotypic variations, in particular, nuclear size and actin cytoskeleton content, but not cell shape. The dependence of cell and nuclear properties on cell-cycle phase is assessed without artifact-prone cell synchronization. To further demonstrate its versatility, this assay is used to quantify the complex interplay among cell cycle, epigenetic modifications, and phenotypic variations following pharmacological treatments affecting DNA integrity, cell cycle, and inhibiting chromatin-modifying enzymes.Chambliss, A. B., Wu, P.-H., Chen, W.-C., Sun, S. X., Wirtz, D. Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single-cell resolution.
引用
收藏
页码:2667 / 2676
页数:10
相关论文
共 22 条
[1]
Anticancer activities of histone deacetylase inhibitors [J].
Bolden, Jessica E. ;
Peart, Melissa J. ;
Johnstone, Ricky W. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) :769-784
[2]
Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide [J].
Chang, J. ;
Varghese, D. S. ;
Gillam, M. C. ;
Peyton, M. ;
Modi, B. ;
Schiltz, R. L. ;
Girard, L. ;
Martinez, E. D. .
BRITISH JOURNAL OF CANCER, 2012, 106 (01) :116-125
[3]
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study [J].
Chavez-Blanco, Alma ;
Segura-Pacheco, Blanca ;
Perez-Cardenas, Enrique ;
Taja-Chayeb, Lucia ;
Cetina, Lucely ;
Candelaria, Myrna ;
Cantu, David ;
Gonzalez-Fierro, Aurora ;
Garcia-Lopez, Patricia ;
Zambrano, Pilar ;
Perez-Plasencia, Carlos ;
Cabrera, Gustavo ;
Trejo-Becerril, Catalina ;
Angeles, Enrique ;
Duenas-Gonzalez, Alfonso .
MOLECULAR CANCER, 2005, 4 (1)
[4]
Functional interplay between the cell cycle and cell phenotypes [J].
Chen, Wei-Chiang ;
Wu, Pei-Hsun ;
Phillip, Jude M. ;
Khatau, Shyam B. ;
Choi, Jae Min ;
Dallas, Matthew R. ;
Konstantopoulos, Konstantinos ;
Sun, Sean X. ;
Lee, Jerry S. H. ;
Hodzic, Didier ;
Wirtz, Denis .
INTEGRATIVE BIOLOGY, 2013, 5 (03) :523-534
[5]
Dasgupta AR, 2006, IEEE SPECTRUM, V43, P8
[6]
Histone deacetylases (HDACs): characterization of the classical HDAC family [J].
De Ruijter, AJM ;
Van Gennip, AH ;
Caron, HN ;
Kemp, S ;
Van Kuilenburg, ABP .
BIOCHEMICAL JOURNAL, 2003, 370 :737-749
[7]
Molecular origins of cancer: Epigenetics in cancer [J].
Esteller, Manel .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) :1148-1159
[8]
Cancer epigenomics: DNA methylomes and histone-modification maps [J].
Esteller, Manel .
NATURE REVIEWS GENETICS, 2007, 8 (04) :286-298
[9]
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer [J].
Fraga, MF ;
Ballestar, E ;
Villar-Garea, A ;
Boix-Chornet, M ;
Espada, J ;
Schotta, G ;
Bonaldi, T ;
Haydon, C ;
Ropero, S ;
Petrie, K ;
Iyer, NG ;
Pérez-Rosado, A ;
Calvo, E ;
Lopez, JA ;
Cano, A ;
Calasanz, MJ ;
Colomer, D ;
Piris, MA ;
Ahn, N ;
Imhof, A ;
Caldas, C ;
Jenuwein, T ;
Esteller, M .
NATURE GENETICS, 2005, 37 (04) :391-400
[10]
HEPPNER GH, 1984, CANCER RES, V44, P2259